Difference between revisions of "PCAT6"
(→Function) |
|||
| Line 1: | Line 1: | ||
| + | ''PCAT6'': prostate cancer associated transcript 6, promotes cellular proliferation and colony formation of prostate cancer. | ||
==Annotated Information== | ==Annotated Information== | ||
===Name=== | ===Name=== | ||
| − | ''PCAT6'': prostate cancer associated transcript 6 ( | + | ''PCAT6'': prostate cancer associated transcript 6 [https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:43714 (HGNC:43714)] |
| + | ===Aliases=== | ||
| + | ncRNA-a2; PCAN-R1: prostate cancer-associated noncoding RNA 1; KDM5BAS1: KDM5B antisense RNA 1 (head to head); onco-lncRNA-96 | ||
| − | + | ===Characteristics=== | |
| − | |||
| − | |||
===Function=== | ===Function=== | ||
| Line 42: | Line 43: | ||
|} | |} | ||
| − | === | + | ===Disease=== |
| − | + | * Lung Cancer <ref name="ref3" /> | |
| − | + | * Prostate Cancer | |
| − | |||
| − | |||
| − | |||
| − | = | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
==Labs working on this lncRNA== | ==Labs working on this lncRNA== | ||
* Centre for Genomic Regulation (CRG), UPF, Barcelona, Spain <ref name="ref1" /> | * Centre for Genomic Regulation (CRG), UPF, Barcelona, Spain <ref name="ref1" /> | ||
| − | |||
| − | |||
* Center for Functional Cancer Epigeneitcs, Dana-Farber Cancer Institute, Boston, Massachusetts, USA <ref name="ref2" /> | * Center for Functional Cancer Epigeneitcs, Dana-Farber Cancer Institute, Boston, Massachusetts, USA <ref name="ref2" /> | ||
| + | * Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China <ref name="ref3" /> | ||
==References== | ==References== | ||
<references> | <references> | ||
| − | <ref name="ref1">Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, et al. Long noncoding RNAs with enhancer-like function in human cells[J]. Cell. 2010,143(1):46-58.</ref>(1) | + | <ref name="ref1"> Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, et al. Long noncoding RNAs with enhancer-like function in human cells[J]. Cell. 2010,143(1):46-58.</ref>(1) |
| + | |||
| + | <ref name="ref2"> Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, et al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer[J]. Nature structural & molecular biology. 2013,20(7):908-13.</ref>(2) | ||
| − | <ref name=" | + | <ref name="ref3"> Wan L, Zhang L, Fan K, Cheng Z-X, Sun Q-C & Wang J-J. Knockdown of Long Noncoding RNA PCAT6 Inhibits Proliferation and Invasion in Lung Cancer Cells[J]. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2016, 24(3):161-170.</ref>(3) |
</references> | </references> | ||
Revision as of 10:15, 21 November 2018
PCAT6: prostate cancer associated transcript 6, promotes cellular proliferation and colony formation of prostate cancer.
Contents
Annotated Information
Name
PCAT6: prostate cancer associated transcript 6 (HGNC:43714)
Aliases
ncRNA-a2; PCAN-R1: prostate cancer-associated noncoding RNA 1; KDM5BAS1: KDM5B antisense RNA 1 (head to head); onco-lncRNA-96
Characteristics
Function
ncRNA-a2 locus in HeLa cells. [1]
Depletion of ncRNA-a2 will result in significant reduction of KLHL12, a gene known for negative regulation of the Wnt-beta catenin pathway [1].
Expression
PCAN-R1 showed positive correlation between gene expression and SCNA. [2]
PCAN-R1, while one isoform PCAN-R1-A was almost identical to the Ensembl annotated transcript ENST00000425295, the other isoform PCAN-R1-B was a spliced variant of PCAN-R1-A with an intron retention. [2]
PCAN-R1 and its neighboring PCG KDM5B showed the highest expression in normal testis. [2]
| Primer | Forward primer | Reverse primer |
|---|---|---|
| RT-PCR | 5′-CAGGAACCCCCTCCTTACTC-3 | 5′-CTAGGGATGTGTCCGAAGGA-3′[2] |
| RACE and northern blot analysis | 5′-GACCTGGGCAACCCCAGCCTG-3′ | 5′-GATCACTAATACGACTCACTATAGGGCGCGAGGAGCGCCTCATCACC-3′[2] |
| RNA interference | siR1-1 | 5′-GGTGTCTCCATCCTCATTC-3′[2] |
| siR1-2 | 5′-CTCCCAGACCTCACGTCAA-3′[2] |
Disease
- Lung Cancer [3]
- Prostate Cancer
Labs working on this lncRNA
- Centre for Genomic Regulation (CRG), UPF, Barcelona, Spain [1]
- Center for Functional Cancer Epigeneitcs, Dana-Farber Cancer Institute, Boston, Massachusetts, USA [2]
- Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [3]
References
- ↑ 1.0 1.1 1.2 Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, et al. Long noncoding RNAs with enhancer-like function in human cells[J]. Cell. 2010,143(1):46-58.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, et al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer[J]. Nature structural & molecular biology. 2013,20(7):908-13.
- ↑ 3.0 3.1 Wan L, Zhang L, Fan K, Cheng Z-X, Sun Q-C & Wang J-J. Knockdown of Long Noncoding RNA PCAT6 Inhibits Proliferation and Invasion in Lung Cancer Cells[J]. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2016, 24(3):161-170.
Sequence
>gi|375268763|ref|NR_046325.1| Homo sapiens prostate cancer associated transcript 6 (non-protein coding) (PCAT6), transcript variant 1, long non-coding RNA
000001 GACGCCCCAG AGGCCGGACC TGGGCAACCC CAGCCTGGAG GTGCCGGGGC CGGAGCTCCC AGAGGGCTGG GTGCGAGGCC 000080
000081 TAGGCGGGGT CAGGTTCGGG TTCCTAGGCC ATAGCGGAGC TGCAGCCCAG GCGGCCGGAG CGGAACCCAG CCCCGCTCCG 000160
000161 AGTGCCACGT CTCCAGGAAC CCCCTCCTTA CTCTTGGACA ACACTCCGCC CCCGCCCGGG CCTCCGTCCC CCAAACCGCC 000240
000241 CTCATTTGTG CAGCGCCAGA TCCTTCGGAC ACATCCCTAG GTGTCTCCAT CCTCATTCGG TCCATCCAAC TCCCAGACCT 000320
000321 CACGTCAACC GGCTGCACCC CACTTTCCAG CCTGCGCCCC AGATCTGCAG CCTTCGCCCC TAGATACACC CGCCTGGTGA 000400
000401 TGAGGCGCTC CTCGCGTTCC TTCCGGGCTC CAGGTGTCCG TGAGCCTCCC TTCCGCCCTG GCCTCCGGTC TCTGCCTTGC 000480
000481 TCGTGCTTCT ACCACCACCC TTCCCCTCCC AACCCGGTGG ATCCTCTCGT CTCCCCCAGT CTCCAGTGCA CCGGCTTTCC 000560
000561 CTCGTCCTCT GCGCAGTCCA TCTCAGCTCA TCTCTCCAAT TCAATGCCAT CATCTCTCCT CACCATCTCT CGGTGCCCTG 000640
000641 GAATGTTTGC TGTCAGATGT CCCCTGTGAA ACCCACAAAC GCTTGCGATT TGGCCTCCTT GTTTTATTTT GTGTAGTCCT 000720
000721 ACAACGTCTT GTTACTACCC CCTATTACAA CACTTATAAC TCAG
000081 TAGGCGGGGT CAGGTTCGGG TTCCTAGGCC ATAGCGGAGC TGCAGCCCAG GCGGCCGGAG CGGAACCCAG CCCCGCTCCG 000160
000161 AGTGCCACGT CTCCAGGAAC CCCCTCCTTA CTCTTGGACA ACACTCCGCC CCCGCCCGGG CCTCCGTCCC CCAAACCGCC 000240
000241 CTCATTTGTG CAGCGCCAGA TCCTTCGGAC ACATCCCTAG GTGTCTCCAT CCTCATTCGG TCCATCCAAC TCCCAGACCT 000320
000321 CACGTCAACC GGCTGCACCC CACTTTCCAG CCTGCGCCCC AGATCTGCAG CCTTCGCCCC TAGATACACC CGCCTGGTGA 000400
000401 TGAGGCGCTC CTCGCGTTCC TTCCGGGCTC CAGGTGTCCG TGAGCCTCCC TTCCGCCCTG GCCTCCGGTC TCTGCCTTGC 000480
000481 TCGTGCTTCT ACCACCACCC TTCCCCTCCC AACCCGGTGG ATCCTCTCGT CTCCCCCAGT CTCCAGTGCA CCGGCTTTCC 000560
000561 CTCGTCCTCT GCGCAGTCCA TCTCAGCTCA TCTCTCCAAT TCAATGCCAT CATCTCTCCT CACCATCTCT CGGTGCCCTG 000640
000641 GAATGTTTGC TGTCAGATGT CCCCTGTGAA ACCCACAAAC GCTTGCGATT TGGCCTCCTT GTTTTATTTT GTGTAGTCCT 000720
000721 ACAACGTCTT GTTACTACCC CCTATTACAA CACTTATAAC TCAG
